S. aureus nasal carriage among hemodialysis (HD) patients [4]

Clinical Nephrology

Volumn 65, Issue 3, 2006, Pages 229-230

  Mountricha, A ^a,b   Platsouka, E ^a   Pappas, C ^a   Vourli, S ^a   Velonakis, E ^a   Hadjiconstantinou, V ^a   Vatopoulos, A ^a   Paniara, O ^a  

^a IASO GENERAL HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

METICILLIN;

ANTIBIOTIC SENSITIVITY; BACTERIUM CARRIER; CLINICAL ARTICLE; CONTROLLED STUDY; GREECE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; HYPERKALEMIA; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NOSE SMEAR; OUTPATIENT CARE; PREVALENCE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STATISTICAL SIGNIFICANCE; TERTIARY HEALTH CARE;

EID: 33644747184     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp65229     Document Type: Letter

References (6)

1. Boelaert JR, van Landuyt HW, De Baere YA et al 1994 Epidemiology and prevention of Staphylococcus aureus infections during hemodialysis. Nephrologie 15: 157-161
2. Boyce JM 1996 Preventing staphylococcal infections by eradicating nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 17:775-779
3. Goldblum SE, Ulrich JA, Goldman RS et al 1982 Nasal and cutaneous flora among hemodialysis patients and personnel: quantitative and qualitative characterization and patterns of staphylococcal carriage. Am J Kidney Dis 2: 281-286
4. Herwaldt LA 1998 Reduction of Staphylococcus aureus nasal carriage and infection in dialysis patients. J Hosp Infect 40: S13-S23
5. Vourli S, Perimeni D, Makri A et al 2005 Community acquired MRSA infections in a pediatric population in Greece. Eurosurveillance May 2005, vol 10 issue 5 Available on line at: http://www.eurosurveillance.org/em/v10n05/1005-224.asp
6. Witte W, Cuny C, Strommenger B et al 2004 Emergence of a new community acquired MRSA strain in Germany. Eurosurveillance 9: 1-2